Unichem Laboratories completes sale of 19.97% equity shares in Optimus

26 Sep 2022 Evaluate

Unichem Laboratories has completed the sale of 19.97% equity shares in Optimus Drugs (Optimus) to Sekhmet Pharmaventures on September 22, 2022. The company has received payment of around Rs 270.98 crore towards completion of sale of first tranche. For the second tranche, the price to be determined as per the said share purchase agreement after satisfaction of necessary conditions precedent.

Incorporated on December 2, 2003, Optimus is engaged in the business of researching, developing, manufacturing, marketing, and distribution of active pharmaceutical ingredients and intermediates.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.

Unichem Lab Share Price

431.45 -11.25 (-2.54%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 901.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×